Genetron Health is a leading precision oncology company in China that specializes in cancer molecular profiling, harnessing advanced technologies in molecular biology and data science to transform cancer care. Genetron has developed a comprehensive oncology platform that covers the entire spectrum of cancer management, addressing challenges ranging from early screening and molecular diagnostics to treatment recommendations and prognostic monitoring. To expand applications of cancer profiling technology, Genetron partners with leading genomic sequencing enterprises as well as global biopharmaceutical companies to offer customized services and products across the entire industry value chain.
At Genetron, we firmly believe in using the best tools that science and technology has to offer for our work, and we hold ourselves to the most rigorous of international standards. From academic research to laboratory operations, precision insights require consistent and thorough processes.
Each patient’s journey through cancer is a fiercely personal experience. Whether it’s targeted treatment, continuous monitoring, or actionable guidance, Genetron’s precision solutions are crafted with an emphasis on personalization and participation—for patients and partners alike.
Breakthrough innovations and the transformations they catalyze are enabled by a zeal for life and empathy for people. Genetron’s core values (B.R.A.V.E.) foster a culture that empowers each of us to navigate ambiguity and discover solutions anchored by the needs of those we serve.